- Cash receipts from customers $298k (up from previous quarter $273K)
- soft launch of Company's plant-based skincare products scheduled for November 2021 at the Hemp, Health and Innovation Expo
- Company's first order of Canntab's cannabinoid hard pill formulations has been received
- Western Sydney University has completed the first draft clinical trial protocol
- Forums
- ASX - By Stock
- CGB
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-2
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)